Euphora™ EUP3530XRecalls & reported problems
Medtronic, Inc. · BALLOON EUP3530X EUPHORA RX US · Class 2
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 2
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00643169560314), received between May 13, 2020 and May 13, 2020 — classified as 1 malfunction.
The most frequently reported specific device problem is “Deflation Problem” (1 report).
2 FDA recall records name this device's identifier, 1 still open.
1 other recall cover devices cleared under the same FDA submission (K143480); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Recalls naming this device
- Sep 3, 2019Open, Classified
Medtronic has determined that some catheters have a slightly higher diameter stylette causing removal difficulties.
Z-0122-2020 · Root cause: Under Investigation by firm · FDA record ↗
- Jul 13, 2017Terminated
Stylette removal difficulties on the Euphora and Solarice products.
Z-3136-2017 · Root cause: Process design · FDA record ↗
Most reported problems
Device problems
- Deflation Problem1
Patient problems
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 13, 2020Deflation Problem; Deflation Problem
A EUPHORA RX BALLOON WAS INTENDED TO BE USED DURING A PROCEDURE TO TREAT A LESION IN THE MID RCA, EXHIBITING MODERATE TORTUOSITY AND MODERATE CALCIFICATION. STENOSIS WAS 90%. THERE WAS NO DAMAGE NOTED TO PACKAGING, AND THE DEVICE WAS INSPECTED WITH NO ISSUES NOTED. NEGATIVE PREP WAS PERFORMED WITH NO ISSUES. THE LESION WAS NOT PRE-DILATED. THE DEVICE DID PASS THROUGH A PREVIOUSLY DEPLOYED STENT. RESISTANCE WAS ENCOUNTERED WHEN ADVANCING THE DEVICE AND EXCESSIVE FORCE WAS NOT USED DURING DELIVERY. IT IS REPORTED THAT BALLOON DEFLATION DIFFICULTIES OCCURRED - THE BALLOON WOULD NOT DEFLATE AT THE LESION SITE. THE PHYSICIAN REMOVED THE DEVICE WHILE INFLATED, AFTER MULTIPLE ATTEMPTS TO DEFLATE. NO PATIENT INJURY REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10050823 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K143480. One submission often covers many models, so check the product and lot details in each record.
- Z-3137-2017 · Jul 13, 2017 · TerminatedSolarice Rapid Exchange Balloon Dilatation Catheter, a Percutaneous Transluminal Coronary Angioplasty (PTCA) Rapid Exchange System.
Other Catheters, transluminal coronary angioplasty, percutaneous devices
- MINI TREK™ 1012270-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous223 reports
- Maverick²™ H7493892815200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous1 death203 reports
- MINI TREK™ 1012270-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous162 reports
- Maverick²™ H7493892820200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous161 reports
- NC TREK 1012454-08Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 recalls59 reports
- TREK™ 1012272-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 deaths158 reports
- NC TREK 1012453-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall84 reports
- NC TREK 1012453-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall1 death83 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.